Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Shanzhiside methylester reduces neuropathic pain by activating spinal GLP-1 receptors and subsequently stimulating microglial β-endorphin expression via the p38 MAPK signaling.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 15,000 | |||
10 mg | 在庫あり | ¥ 26,500 | |||
25 mg | 在庫あり | ¥ 48,500 | |||
50 mg | 在庫あり | ¥ 72,000 |
分子量 | 406.38 |
分子式 | C17H26O11 |
CAS No. | 64421-28-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 199.3 mM
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Shanzhiside methyl ester 64421-28-9 GPCR/G Protein Glucagon Receptor inhibit Inhibitor neuropathic anti-allodynic GCGR GLP-1 inhibitor